10X Genomics Inc vs Wendys Co — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Wendys Co trades at $7.64 (market cap $1.50B). The key difference: 10X Genomics Inc is far larger — about 3.7× Wendys Co's market cap, and Wendys Co pays a 7.13% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | WEN | |
|---|---|---|
Market Cap | $5.48B | $1.50B |
Sector | Health | Consumer Cyclical |
52-Week High | $45.80 | $11.33 |
52-Week Low | $11.34 | $6.17 |
Enterprise Value | $5.02B | $5.31B |
Dividend Yield | — | 7.13% |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →